Proprietary comp report by Overheard on Wall Street.
Harvard's endowment got rekt by private equity and hedge funds, but private equity professionals expect double-digit raises in 2024.
Private equity and venture capital firms from Silicon Valley to Wall Street are pumping millions of dollars into the psychedelic revolution. Investors are betting on the power of mind-bending drugs to transform mental health treatment and cut costs.
Plus: S&P 500 posts best month since 2023, 78% companies beat earnings, Zuck's made $1B in Meta dividends, and Jamie Dimon is sounding the alarm on the bond market.
Goldman Sachs Research expects gold prices to be propelled by multi-year demand from central banks.
Thank you for 500K on Instagram and 1M+ across all platforms.
Plus: Trump and Powell finally meet, Grammarly raised $1B from General Catalyst, Victoria's secret goes dark after security breach, and Apollo partners with major U.S. banks.
Plus: Nvidia beats earnings (yawn), stock pops 5%, Trump’s reciprocal tariffs get blocked, Elon exits the White House, and Hailey Bieber lands a unicorn exit.
Plus: PE fundraising plunges 35%, Citadel Securities profits jump 70%, McKinsey cut more than 10% of its staff, and Salesforce bought Informatica for $8 billion
Plus: Crypto is burning the haters, RedBird buys The Telegraph, Jamie Dimon keeps slamming remote work, Alex Karp sells PLTR stock, and Booz Allen cuts 2.5K jobs.
We’ve barely scratched the surface of the total opportunity in robotics.
Plus: End of penny production, Fannie Mae and Freddie Mac stocks mooning, OnlyFans eyes a $8 billion sale, and 'buying the dip' might be a guy thing.
Plus: Bitcoin up ~50% off April lows, hits $112K ATH, generational bag fumble from Apple as Jony Ive joins OpenAI, and NYC's hottest new workout class.
Plus: Elon Musk commits to staying at Tesla for 5 years, Pfizer enters the cancer drug race, and Cathie Wood's wild price targets for Tesla and Bitcoin.
Plus: Retail investors shrugged off Moody’s downgrade with record dip-buying, Regeneron scooped up 23andMe, Dimon softened on Bitcoin, and AI may kill the ETF boom.
